TCIM
TVTX icon

TIAA CREF Investment Management’s Travere Therapeutics TVTX Stock Holding History

TIAA CREF Investment Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7.85M Sell
347,017
-232,359
-40% -$5.13M 0.01% 1170
2018
Q4 		$13.1M Sell
579,376
-2,146
-0.4% -$53.4K 0.01% 826
2018
Q3 		$16.7M Sell
581,522
-203,607
-26% -$5.82M 0.01% 817
2018
Q2 		$21.4M Buy
785,129
+151,363
+24% +$4.03M 0.01% 710
2018
Q1 		$14.2M Sell
633,766
-11,753
-2% -$280K 0.01% 923
2017
Q4 		$13.6M Sell
645,519
-6,533
-1% -$149K 0.01% 972
2017
Q3 		$16.2M Buy
652,052
+23,241
+4% +$512K 0.01% 861
2017
Q2 		$12.2M Sell
628,811
-7,734
-1% -$140K 0.01% 1018
2017
Q1 		$11.8M Buy
636,545
+421,515
+196% +$8.25M 0.01% 1015
2016
Q4 		$4.07M Sell
215,030
-5,220
-2% -$107K ﹤0.01% 1734
2016
Q3 		$4.93K Buy
220,250
+59,493
+37% +$1.13M ﹤0.01% 1622
2016
Q2 		$2.86M Buy
160,757
+34,116
+27% +$552K ﹤0.01% 1911
2016
Q1 		$1.73M Hold
126,641
– – ﹤0.01% 2165
2015
Q4 		$2.44M Sell
126,641
-4,878
-4% -$97.4K ﹤0.01% 2026
2015
Q3 		$2.67M Sell
131,519
-5,509
-4% -$163K ﹤0.01% 1973
2015
Q2 		$4.54M Buy
137,028
+37,652
+38% +$1.03M ﹤0.01% 1761
2015
Q1 		$2.38M Buy
99,376
+9,608
+11% +$147K ﹤0.01% 2132
2014
Q4 		$1.1M Sell
89,768
-45,621
-34% -$472K ﹤0.01% 2599
2014
Q3 		$1.22M Sell
135,389
-22,870
-14% -$269K ﹤0.01% 2525
2014
Q2 		$1.86M Buy
158,259
+87,242
+123% +$1.18M ﹤0.01% 2343
2014
Q1 		$1.51M Buy
+71,017
New +$1.09M ﹤0.01% 2400

Other funds holding TVTX

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TIAA CREF Investment Management's TVTX Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Travere Therapeutics (TVTX) stake by 40% in Q1 2019, selling an estimated $5.13M and leaving 347,017 shares worth $7.85M. The position accounts for 0.01% of the portfolio, ranked #1170.

TIAA CREF Investment Management first reported a position in TVTX in Q1 2014 and has held it in 21 quarters since. The position peaked at $21.4M in Q2 2018. 131 funds tracked by Wall St. Rank hold TVTX as of Q1 2019.

  • TIAA CREF Investment Management held 347,017 shares of Travere Therapeutics worth $7.85M as of Q1 2019.
  • TIAA CREF Investment Management sold 232,359 Travere Therapeutics shares in Q1 2019, an estimated $5.13M.
  • Travere Therapeutics made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1170 holding.
  • TIAA CREF Investment Management first reported a position in Travere Therapeutics in Q1 2014 and has held it in 21 quarters since.
  • TIAA CREF Investment Management's Travere Therapeutics position peaked at $21.4M in Q2 2018.
  • 131 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.